Dr Borremans
ActiveDr Borremans has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2k and a net result of €105k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 5% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Checked score
Score 2025
70
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency26=
Growth58=
Track record94
Bankruptcy probability, 12 months
0.3%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit advice for your own amount and term
Signals
Eight signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
0.6%
Return on assets
43.5%
Age of the figures
9 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 5% of 16546 sector peers (2025).
NBB · sector comparisonPosition among 16546 sector peers
Solvency
better than 5%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 10-03-2026, 143 days ahead of the deadline.
NBB · 6 filingsDeviation from the deadline
2025
143 d early
2024
125 d early
2023
90 d early
2022
125 d early
2021
80 d early
2020
43 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
23-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€2k=
2024 · €2k
2020: €14k
2021: €96k
2022: €174k
2023: €2k
2024: €2k
2020 → 2025
Total assets
€240k▲ 36.7%
2024 · €176k
2020: €46k
2021: €129k
2022: €207k
2023: €206k
2024: €176k
2020 → 2025
Net result
€105k▲ 29.5%
2024 · €81k
2020: €13k
2021: €83k
2022: €79k
2023: €75k
2024: €81k
2020 → 2025
Working capital
€-5k▼ 27.6%
2024 · €-4k
2020: €-12k
2021: €78k
2022: €162k
2023: €-5k
2024: €-4k
2020 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€96k-€174k▲ 80.9%€2k▼ 99.1%€2k=€2k=
Operating result€107k-€102k▼ 5.4%€103k▲ 1.3%€103k=€134k▲ 30.1%
Net result€83k-€79k▼ 5.6%€75k▼ 4.6%€81k▲ 7.6%€105k▲ 29.5%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 30% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €240k
Fixed assets
€7k▲ 20.3%
Current assets
€233k▲ 37.3%
Equity and liabilities €240k
Equity
€2k=
Debt
€239k▲ 37.1%
The debt ratio rises from 99.1% to 99.4%. Debt is higher.
Key figures and ratios
EBITDA
€135k▲
2024 · €109k
Cash flow
€106k▲
2024 · €86k
Solvency
0.6%▼
2024 · 0.9%
Current ratio
0.98▲
2024 · 0.98
Quick ratio
0.98▲
2024 · 0.98
ROA
43.5%▼
2024 · 46.0%
Interest coverage
238.55▲
2024 · 162.14
Debt
€239k▲
2024 · €174k
Debt ≤ 1 year
€239k▲
2024 · €174k
Income taxes
€30k▲
2024 · €22k
A ratio outside any meaningful range has been withheld (balance sheet total €240k, equity €2k).
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€176k€240k▲
Formation expenses20€0€0=
Fixed assets21/28€6k€7k▲
Tangible fixed assets22/27€6k€7k▲
Plant, machinery and equipment23€669€2k▲
Furniture and vehicles24€0€0=
Other tangible fixed assets26€5k€4k▼
Current assets29/58€170k€233k▲
Amounts receivable within one year40/41€11k€5k▼
Trade receivables40€6k€5k▼
Other amounts receivable41€5k-
Current investments50/53€25k€25k=
Cash at bank and in hand54/58€133k€202k▲
Deferred charges and accrued income490/1€1k€1k▼
Equity and liabilities
Total equity and liabilities10/49€176k€240k▲
Equity10/15€2k€2k=
Contributions10/11€2k€2k=
Amounts payable17/49€174k€239k▲
Amounts payable within one year42/48€174k€239k▲
Trade debts44€536€1k▲
Suppliers440/4€536€1k▲
Taxes, remuneration and social security45€2k€11k▲
Taxes450/3€2k€11k▲
Other amounts payable47/48€172k€226k▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€6k€1k▼
Other operating charges640/8€626€643▲
Gross operating margin9900€109k€136k▲
Operating profit (loss)9901€103k€134k▲
Financial income75/76B€0€900▲
Recurring financial income75€0€900▲
Financial charges65/66B€671€567▼
Recurring financial charges65€671€567▼
Profit (loss) for the period before taxes9903€102k€134k▲
Income taxes67/77€22k€30k▲
Profit (loss) for the period9904€81k€105k▲
Profit (loss) for the period to be appropriated9905€81k€105k▲
Appropriation of the result
Profit (loss) to be appropriated9906€81k€105k▲
Profit to be distributed694/7€81k€105k▲
Return on contributions (dividend)694€78k€105k▲
Directors or managers695€3k-
The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
10-03
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Highest result since 2020net €105k ▲29.5%
Operating result €134k, net result €105k, both a record.
28-03
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
02-05
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
28-03
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Equity above €150kEq €174k ▲80.9%
3 profitable years in a row build equity to €174k.
12-05
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial
Liquidity times 5current ratio 3.40
Current ratio from 0.63 to 3.40; short-term debt falls from €32k to €32k.
18-06
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Etterbeek · 1 establishment unit since 2020
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Batavierenstraat 21040 EtterbeekGround area
84 m²
Building footprint
84 m²
Volume, LiDAR
737 m³
Parcel 21005A0564/00G006, Brussels · tallest building 14.4 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
Dr Borremans
since 20202.309.879.311
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21005A0564/00G006 | Brussels | 84 m² | 1 · 84 m² | 14.4 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
MAPIALEJ
BE 0729.570.751
Overijse · Eq €2k
GH Cardiologist
BE 0775.754.035
Marche-en-Famenne · Eq €2k
Dr. GAETHAN MAES
BE 0778.898.617
Gent · Eq €2k
Dr J-B Duquenne, pneumologie
BE 0783.519.676
Sprimont · Eq €2k
Cabinet de psychiatrie Dr A-S L
BE 0790.405.389
Liège · Eq €2k
Of 16,627 companies in sector 86220 we hold annual accounts for 7,974. 620 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded03-11-2020
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 6 filingsAddress and cadastre registers
Data from official sources, last processed on 23-09-2026. Scores and ratios are computed by Checked and are not a credit decision.
Contact details
2 entriesE-mail:drborremansh@gmail.com
Phone:+32475372871